Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy | |
Wang, Xiao-Bing; Jiang, Xing-Ran; Yu, Xi-Ying; Wang, Lin; He, Shun; Feng, Fei-Yue; Guo, Li-Ping; Jiang, Wei; Lu, Shih-Hsin | |
2014 | |
卷号 | 105期号:2页码:176-185 |
关键词 | Diagnosis esophageal squamous cell carcinoma macrophage inhibitory factor 1 prognosis target |
ISSN号 | 1349-7006 |
DOI | 10.1111/cas.12331 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6682528 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Wang, Xiao-Bing,Jiang, Xing-Ran,Yu, Xi-Ying,et al. Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy[J],2014,105(2):176-185. |
APA | Wang, Xiao-Bing.,Jiang, Xing-Ran.,Yu, Xi-Ying.,Wang, Lin.,He, Shun.,...&Lu, Shih-Hsin.(2014).Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.,105(2),176-185. |
MLA | Wang, Xiao-Bing,et al."Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy".105.2(2014):176-185. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论